Skip to content

Andrew C. Harris, M.D.

NPI 1356546493ActiveIndividual· Pediatrics, Pediatric Hematology-Oncology· New York, NY

Pediatrics, Pediatric Hematology-Oncology (M.D.) in New York, New York, licensed in NY and MI, with an NPI issued in June 2007. Enrolled in Medicare as practitioner - hematology/oncology. Genzyme Corporation was the largest of 6 companies reporting payments in 2025, $21,363 in all, mostly consulting fees.

Overview

NPI1356546493
StatusActive
Entity typeIndividual
CredentialM.D.
Sole proprietorNo
NPI issuedJun 19, 2007
Last updated in NPPESAug 13, 2021
Certified by providerAug 13, 2021

Specialties and licenses

About license numbers in NPPES

Exclusion screening

ListResultDetails
HHS-OIG LEIE · Oct 9, 2026No matchChecked by NPI and by name + state
North Carolina Medicaid · Nov 10, 2026No match—
New York OMIG · Nov 10, 2026No match—
Ohio Medicaid · Nov 10, 2026No match—
Pennsylvania Medicheck · Nov 10, 2026No match—
Washington HCA · Nov 10, 2026No match—

Official OIG search · How matching works ·Bulk check a roster

Medicare

Enrollment (PECOS)Enrolled Practitioner - Hematology/Oncology (NY)

Medicare sources and data years

Industry payments (Open Payments)

  • 2025$21,363 · 16 payments from 6 companies
  • 2024$27,537 · 35 payments from 5 companies

Top paying companies in 2025

What the 2025 payments were for

  • Consulting Fee$16,467 · 5 payments
  • Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program$3,720 · 1 payment
  • Food and Beverage$617.74 · 7 payments
  • Travel and Lodging$558.31 · 3 payments

Receiving payments does not imply wrongdoing. What Open Payments covers ·original records

Other Pediatrics, Pediatric Hematology-Oncology providers in New York

All Pediatrics, Pediatric Hematology-Oncology providers in New York →